Lynne Cox @ 2024 Biomarkers of Aging Conference

Lynne Cox introduces how Wellcome Leap builds bold, unconventional programs and funds them at scale. These programs aim to achieve breakthroughs in human health within 5-10 years, delivering seemingly impossible results on seemingly impossible timelines. She highlights Wellcome Leap's support for the clinical translation of biomarkers of aging - specifically biomarkers of resilience - through their Dynamic Resilience (DR) Program.
Timestamps:
[00:00:45] Intro to Wellcome Leap
[00:01:44] Why focus on resilience?
[00:04:31] Stress reveals biomarkers of resilience
[00:08:20] Goals of the Dynamic Resilience program
[00:10:14] DR's global team of performers
[00:10:49] Identifying markers of dynamic resilience in humans
[00:12:50] New tools are needed for measurement of dynamic resilience
[00:13:49] Causal biomarkers of centenarian resilience & their clinical validation
Dr. Lynne Cox is the Program Director 'Dynamic Resilience' at Wellcome Leap, a global ARPA for health. You can learn more about Wellcome Leap's DR program here: wellcomeleap.o...